Gagelmann, N., Witte, M. d., Peczynski, C., Boreland, W., Broers, A. E. C., Jost, E., . . . Peric, Z. (2025). Daratumumab for PRCA after HCT: Study and practical considerations from the EBMT Transplant Complications Working Party.
Citación estilo ChicagoGagelmann, Nico, et al. Daratumumab for PRCA After HCT: Study and Practical Considerations From the EBMT Transplant Complications Working Party. 2025.
Cita MLAGagelmann, Nico, et al. Daratumumab for PRCA After HCT: Study and Practical Considerations From the EBMT Transplant Complications Working Party. 2025.
Precaución: Estas citas no son 100% exactas.